Impending LDC Graduation Poses Threats to Nepal’s Pharmaceutical Industry: Study
Nepal’s graduation from the least developed country (LDC) category in 2026 will impact access to generics medicines produced by domestic drug manufacturers of Nepal, according to a study report prepared by South Asia Watch on Trade, Economics and Environment (SAWTEE).
Issuing a recent press statement, SAWTEE said Nepal’s pharmaceutical sector faces significant challenges due to the loss of flexibilities under the World Trade Organization’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) as the country approaches its graduation from the LDC category in 2026.